Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells

Immune dysregulation drives the pathogenesis of chronic inflammatory, autoimmune and dysplastic disorders. While often intended to address localized pathology, most immune modulatory therapies are administered systemically and carry inherent risk of multi-organ toxicities. Here we demonstrate, in a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Res
Egile Nagusiak: Chung, Allen Y., Li, Qingsheng, Blair, Sarah J., De Jesus, Magdia, Dennis, Kristen L., LeVea, Charles, Yao, Jin, Sun, Yijun, Conway, Thomas F., Virtuoso, Lauren P., Battaglia, Nicholas G., Furtado, Stacia, Mathiowitz, Edith, Mantis, Nicholas J., Khazaie, Khashayarsha, Egilmez, Nejat K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4322772/
https://ncbi.nlm.nih.gov/pubmed/25228656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-0918
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak